Cargando…
Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya
BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086393/ https://www.ncbi.nlm.nih.gov/pubmed/30096177 http://dx.doi.org/10.1371/journal.pone.0200199 |
_version_ | 1783346503025164288 |
---|---|
author | Larson, Bruce A. Bii, Margaret Halim, Nafisa Rohr, Julia K. Sugut, William Sawe, Fredrick |
author_facet | Larson, Bruce A. Bii, Margaret Halim, Nafisa Rohr, Julia K. Sugut, William Sawe, Fredrick |
author_sort | Larson, Bruce A. |
collection | PubMed |
description | BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiated on ART during pregnancy over the first one and two years on treatment. The study site was the District Hospital in Kericho, Kenya. METHODS: A micro-costing approach from the provider’s perspective, based on a retrospective review of patient medical records, was used to evaluate incremental costs of care (2012 USD). Cost per patient in two cohorts were evaluated: the MCH clinic group comprised of adult women who initiated ART at the site’s MCH clinic during pregnancy between 2008–2011; and for comparison, the ART clinic group comprised of adult, non-pregnant women who initiated ART at the site’s ART clinic during 2008–2011. The two groups were matched on age and baseline CD4 count at initiation. Retention at year one/two on ART was defined as having completed a clinic visit at 365/730 days on ART +/- 90 days. RESULTS: For patients defined as retained in care at year one, average incremental costs per patient were $234 for the MCH clinic group (median: 215; IQR: 186, 282) and $292 in the ART clinic group (median: 227; IQR: 178, 357). ARV and laboratory costs were less on average for the MCH clinic group compared to the ART clinic group (due to lower cost regimens and fewer tests), while personnel costs were higher for the MCH clinic group. CONCLUSIONS: The annual incremental cost per patient of providing ART were similar in the two clinic settings in 2012. With shifts in recommended ARV regimens and lab monitoring over time, annual costs of care (using 2016 USD unit costs) have remained relatively constant in nominal terms for the MCH clinic group but have fallen substantially for the ART clinic group (from nominal $292 in 2012 to nominal $227 in 2016). |
format | Online Article Text |
id | pubmed-6086393 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-60863932018-08-28 Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya Larson, Bruce A. Bii, Margaret Halim, Nafisa Rohr, Julia K. Sugut, William Sawe, Fredrick PLoS One Research Article BACKGROUND: To date, little information exists on the costs of providing antiretroviral therapy (ART) within maternal and child health (MCH) clinics in Kenya. The main objective of this analysis was to estimate the annual incremental cost of providing ART within a MCH clinic for adult women initiated on ART during pregnancy over the first one and two years on treatment. The study site was the District Hospital in Kericho, Kenya. METHODS: A micro-costing approach from the provider’s perspective, based on a retrospective review of patient medical records, was used to evaluate incremental costs of care (2012 USD). Cost per patient in two cohorts were evaluated: the MCH clinic group comprised of adult women who initiated ART at the site’s MCH clinic during pregnancy between 2008–2011; and for comparison, the ART clinic group comprised of adult, non-pregnant women who initiated ART at the site’s ART clinic during 2008–2011. The two groups were matched on age and baseline CD4 count at initiation. Retention at year one/two on ART was defined as having completed a clinic visit at 365/730 days on ART +/- 90 days. RESULTS: For patients defined as retained in care at year one, average incremental costs per patient were $234 for the MCH clinic group (median: 215; IQR: 186, 282) and $292 in the ART clinic group (median: 227; IQR: 178, 357). ARV and laboratory costs were less on average for the MCH clinic group compared to the ART clinic group (due to lower cost regimens and fewer tests), while personnel costs were higher for the MCH clinic group. CONCLUSIONS: The annual incremental cost per patient of providing ART were similar in the two clinic settings in 2012. With shifts in recommended ARV regimens and lab monitoring over time, annual costs of care (using 2016 USD unit costs) have remained relatively constant in nominal terms for the MCH clinic group but have fallen substantially for the ART clinic group (from nominal $292 in 2012 to nominal $227 in 2016). Public Library of Science 2018-08-10 /pmc/articles/PMC6086393/ /pubmed/30096177 http://dx.doi.org/10.1371/journal.pone.0200199 Text en © 2018 Larson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Larson, Bruce A. Bii, Margaret Halim, Nafisa Rohr, Julia K. Sugut, William Sawe, Fredrick Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title | Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title_full | Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title_fullStr | Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title_full_unstemmed | Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title_short | Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya |
title_sort | incremental treatment costs for hiv-infected women initiating antiretroviral therapy during pregnancy: a 24-month micro-costing cohort study for a maternal and child health clinic in kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086393/ https://www.ncbi.nlm.nih.gov/pubmed/30096177 http://dx.doi.org/10.1371/journal.pone.0200199 |
work_keys_str_mv | AT larsonbrucea incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya AT biimargaret incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya AT halimnafisa incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya AT rohrjuliak incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya AT sugutwilliam incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya AT sawefredrick incrementaltreatmentcostsforhivinfectedwomeninitiatingantiretroviraltherapyduringpregnancya24monthmicrocostingcohortstudyforamaternalandchildhealthclinicinkenya |